Overexpression of the receptor tyrosine kinase tie-1 intracellular domain in breast cancer

Tumor Biology

Volumn 24, Issue 2, 2003, Pages 61-69

  Yang, Xi Hui ^a   Hand, Randal A ^a   Livasy, Chad A ^a   Cance, William G ^a   Craven, Rolf J ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Angiogenesis; Epithelial gene expression; Signaling

Indexed keywords

PROTEIN ANTIBODY; PROTEIN TYROSINE KINASE; TIE 1 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST CARCINOMA; BREAST EPITHELIUM; BREAST TUMOR; CANCER CELL; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CARCINOMA IN SITU; CELL TYPE; CELLULAR DISTRIBUTION; COLON TUMOR; CONTROLLED STUDY; ENZYME ACTIVE SITE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR CELL; WESTERN BLOTTING;

EID: 0037633561     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071078     Document Type: Article

References (38)

1. Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL: Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1987;i:1398-1402.
2. Slamon DJ, Clark GM, Wong SJ, Levin LJ, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-182.
3. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 1990;50:48-53.
4. Owens LV, Xu L, Craven RJ, Dent GA, Weiner TM, Kornberg L, Liu ET, Cance WG: Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 1995;55:2752-2755.
5. Kacinski BM, Scata KA, Carter D, Yee LD, Sapi E, King BL, Chambers SK, Jones MA, Pirro MH, Stanley ER, Rohrschneider LR: FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene 1991;6:941-952.
6. Cance WG, Craven RJ, Weiner TM, Liu ET: Novel protein kinases expressed in human breast cancer. Int J Cancer 1993;54:571-577.
7. Partanen J, Makela TP, Alitalo R, Lehvaslaiho H, Alitalo K: Putative tyrosine kinases expressed in K-562 human leukemia cells. Proc Natl Acad Sci USA 1990;87:8913-8917.
8. Partanen J, Armstrong E, Makela TP, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Huebner K, Alitalo K: A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 1992;12:1698-1707.
9. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML: Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994;8:1897-1909.
10. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maquire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995;376:70-74.
11. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J: The receptor tyrosine kinase TIE is required for the integrity and survival of vascular endothelial cells. EMBO J 1995;14:5884-5891.
12. Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M, Alitalo K: Enhanced expression of the Tie-1 receptor tyrosine kinase in endothelial cells during neovascularization. Blood 1992;80:2548-2555.
13. Yabkowitz R, Meyer S, Yanagihara D, Brankow D, Staley T, Elliot G, Hu S, Ratzkin B: Regulation of Tie-1 receptor expression on human endothelial cells by protein kinase C-mediated release of soluble Tie-1. Blood 1997;90:706-715.
14. O'Bryan JP, Fridell YW, Koski R, Varnum B, Liu ET: The transforming receptor tyrosine kinase, Axl, is post-translationally regulated by proteolytic cleavage. J Biol Chem 1995;270:551-557.
15. Yee NS, Hsiau C-WM, Serve H, Vosseller K, Besmer P: Mechanism of down-regulation of c-kit receptor. Roles of receptor tyrosine kinase, phosphotidylinositol 3′-kinase, and protein kinase C. J Biol Chem 1994;269:31991-31998.
16. Downing JR, Roussel MF, Sherr CJ: Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms. Mol Cell Biol 1989;9:2890-2896.
17. Marron MB, Hughes DP, Edge MD, Forder CL, Brindle NPJ: Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2. J Biol Chem 2000;275:39741-39746.
18. Sartor CI, Zhou H, Kozlowska E, Guttridge K, Kawata E, Caskey L, Harrelson J, Hynes N, Ethier S, Calvo B, Earp HS 3rd: Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells. Mol Cell Biol 2001;21:4265-4275.
19. Cance WG, Brennan MF, Dudas ME, Huang CM, Cordon-Cardo C: Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 1990;323:1457-1462.
20. Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, Simkins S, Xu L: Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: Correlation with preinvasive and invasive phenotypes. Clin Cancer Res 2000;6:2417-2423.
21. Kinzler KW, Vogelstein B: Landscaping the cancer terrain. Science 1998;280:1036-1037.
22. Orimo A, Tomioka Y, Shimizu Y, Sato M, Oigawa S, Kamata K, Nogi Y, Inoue S, Takahashi M, Hata T, Maramatsu M: Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clin Cancer Res 2001;7:3097-3105.
23. Harris AL, Reusch P, Barleon B, Hang C, Dobbs N, Marme D: Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy. Clin Cancer Res 2001;7:1992-1997.
24. Zabrecky JR, Lam T, McKenzie SJ: The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3. J Biol Chem 1991;266:1716-1720.
25. Kendall RL, Thomas KA: Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993;90:10705-10709.
26. HER2 causes transformation and tumorigenesis in NIH 3T3 cells. Proc Natl Acad Sci USA 1987;84:7159-7163.
27. Di Fiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR, Schlessinger J, Aaronson SA: Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 1987;51:1063-1070.
28. O'Bryan JP, Frye RA, Cogswell PC, Neubauer A, Kitch B, Prokop C, Espinosa R 3rd, Le Beau MM, Earp HS, Liu ET: axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 1991;11:5016-5031.
29. Xu L-H, Yang X, Bradham CA, Brenner DA, Baldwin AS, Craven RJ, Cance WG: The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. J Biol Chem 2000;275:30597-30604.
30. Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A, Jove R: Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 2001;20:2499-2513.
31. Zhou BP, Hu MC, Miller SA, Yu Z, Xia W, Lin SY, Hung MC: HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. J Biol Chem 2000;275:8027-8031.
32. Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LA, Robinson G, Mercurio AM: Vascular endothelial growth factor is an autocrine survival signal for neuropilin-expressing breast carcinoma cells. Cancer Res 2001;15:5736-5740.
33. Kontos CD, Cha EH, York JD, Peters KG: The endothelial receptor tyrosine kinase Tie1 activates phosphotidylinositol 3-kinase and Akt to inhibit apoptosis. Mol Cell Biol 2002;22:1704-1713.
34. Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD: Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 1984;307:521-527.
35. Salven P, Joensuu H, Heikkila P, Matikainen M-T, Wasenius V-M, Alanko A, Alitalo K: Endothelial Tie-1 growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis. Br J Cancer 1996;74:69-72.
36. Tseng L-M, Hsu C-Y, Wang H-C, Liu JM, Chang H-M, Lo S-S, Wu C-W, Lui W-Y, Chi C-W: Tie-1 tyrosine kinase is an independent prognostic indicator for invasive breast cancer. Anticancer Res 2001;21:2163-2170.
37. Lin W-C, Li AF-Y, Chi C-W, Chung W-W, Huang CL, Lui W-Y, Kung H-J, Wu C-W: Tie-1 protein tyrosine kinase: A novel independent prognostic marker for gastric cancer. Clin Cancer Res 1999;5:1745-1751.
38. Siemeister G, Schirner M, Weindel K, Reusch P, Menrad A, Marme D, Martiny-Baron G: Two independent mechanisms essential for tumor angiogenesis: Inhibition of human melanoma xenograph growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway. Cancer Res 1999;59:3185-3191.